Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 — China, 2020–2021

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Previous studies have reported vaccine efficacy or effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants for several vaccine platforms. However, there are currently few data on estimates of inactivated platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xinhua, Bai, Xufang, Chen, Xinghui, Zheng, Nan, Yang, Juan, Zhang, Juanjuan, Yu, Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061772/
https://www.ncbi.nlm.nih.gov/pubmed/37006710
http://dx.doi.org/10.46234/ccdcw2023.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061772/
https://www.ncbi.nlm.nih.gov/pubmed/37006710
http://dx.doi.org/10.46234/ccdcw2023.019

Ejemplares similares